Sofinnova is a healthcare investment firm with approximately $3.3B in assets under management and committed capital. We invest in both private and public equity in life sciences and biotechnology, specifically in early to growth-stage companies transforming scientific innovation into life-saving treatments.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions